Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Enterprise Value: 2009-2024

Historic Enterprise Value for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $15.0 million.

  • Cumberland Pharmaceuticals' Enterprise Value rose 11532.91% to $31.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.0 million, marking a year-over-year increase of 66.63%. This contributed to the annual value of $15.0 million for FY2024, which is 118.25% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Enterprise Value stood at $15.0 million for FY2024, which was up 118.25% from $6.9 million recorded in FY2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Enterprise Value peaked at $41.9 million during FY2021, and registered a low of $6.9 million during FY2023.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Enterprise Value value was $12.5 million (recorded in 2022), while the average stood at $11.5 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first plummeted by 70.19% in 2022, then soared by 118.25% in 2024.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Enterprise Value stood at $19.5 million in 2020, then spiked by 115.04% to $41.9 million in 2021, then plummeted by 70.19% to $12.5 million in 2022, then slumped by 44.96% to $6.9 million in 2023, then skyrocketed by 118.25% to $15.0 million in 2024.